40
Participants
Start Date
August 22, 2011
Primary Completion Date
July 14, 2016
Study Completion Date
March 26, 2018
Metformin
"metformin 850 mg bid in addition to standard chemotherapy (containing anthracyclines, platinum, taxanes or capecitabine; first or second line).~Number of cycles: Until progression or unacceptable toxicity develops."
Placebo
"Placebo bid in addition to standard chemotherapy (containing anthracyclines, platinum, taxanes or capecitabine; first or second line).~Number of cycles: until progression or unacceptable toxicity develops."
London Regional Cancer Program, London
St. Michael's Hospital, Toronto
Mount Sinai Hospital, Toronto
Princess Margaret Hospital, Toronto
Windsor Regional Cancer Centre, Windsor
Lead Sponsor
Collaborators (1)
Breast Cancer Research Foundation
OTHER
Ozmosis Research Inc.
INDUSTRY